M. Heep

Frequency of <i>rpoB</i> Mutations Inside and Outside the Cluster I Region in Rifampin-Resistant Clinical <i>Mycobacterium tuberculosis</i> Isolates

M. Heep, Barbara Brandstätter, Ulrich M. Rieger et al. · Journal of Clinical Microbiology · 2001 · 232 citations · Full text

Life Sciences, Genetics, Microbiology +16

Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria

Gary J. Noel, Karen Amsler, M. Heep et al. · Antimicrobial Agents and Chemotherapy · 2007 · 190 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Rifampin and Rifabutin Resistance Mechanism in <i>Helicobacter pylori</i>

M. Heep, Daniela Beck, E. Bayerdörffer et al. · Antimicrobial Agents and Chemotherapy · 1999 · 178 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Single-Ascending-Dose Pharmacokinetics and Safety of the Novel Broad-Spectrum Antifungal Triazole BAL4815 after Intravenous Infusions (50, 100, and 200 Milligrams) and Oral Administrations (100, 200, and 400 Milligrams) of Its Prodrug, BAL8557, in Healthy Volunteers

Anne Schmitt‐Hoffmann, Brigitte Roos, M. Heep et al. · Antimicrobial Agents and Chemotherapy · 2005 · 169 citations

Medicine, Pharmacokinetics, Pharmacology +13

Mutations in the Beginning of the <i>rpoB</i> Gene Can Induce Resistance to Rifamycins in both <i>Helicobacter pylori</i> and <i>Mycobacterium tuberculosis</i>

M. Heep, Ulrich M. Rieger, Daniela Beck et al. · Antimicrobial Agents and Chemotherapy · 2000 · 150 citations · Full text

Life Sciences, Microbiology, Molecular Genetics +17